Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

View:
Post by NewToInvesting7 on Apr 08, 2024 3:30pm

Last 2 NRs

Extremely disappointed with the last 2 NRs from StageZero.  With a $25m credit facility available to draw from, plus the options that the BOD has that can be exercised, why is there no money to pay auditors?  Something does not smell right.

If you are managing the company and get paid a hefty compensation package (~C$500k for JHT), why not exercise some of your stock options, even if the exercise price is higher than the current SP, and use the funds to pay the auditors?  Do you not believe in the product you are selling?   

I do believe that the company has a product to sell that will generate revenues, but James Howard-Tripp has failed us yet again.  After this, I would strongly suggest that the shareholders vote out the entire board, save maybe Rory who has some skin in the game.  

Cheers!
Comment by 4real4ever on Apr 08, 2024 4:06pm
Smell CCAA   They sell nothing so no need to believe in their products   Even Rory have to go but you'll never see that before BK  
Comment by NewToInvesting7 on Apr 08, 2024 4:27pm
Doubt we get there.  While StageZero may qualify for CCAA based on total liabilities, I do not see shareholders voting to approve it (if it even gets to that point).  Don't forget that a significant amount of the liabilities are compensation related and the company has access to funding.   Plus any competent Monitor looking at this would see right through JHT's BS ...more  
Comment by 4real4ever on Apr 08, 2024 6:02pm
No votes are needed for CCAA   Even with $25M if it's true they can do it
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities